CoChat

Serum 1,5-Anhydroglucitol (GlycoMark™): A Short-Term Glycemic Marker

Buse, John B., Freeman, Jennifer L. R., Edelman, Steven V., Jovanovic, Lois, McGill, Janet B. · 2003 · Diabetes Technology & Therapeutics

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

1,5-Anhydroglucitol (1,5-AG), the 1-deoxy form of glucose, has been measured and used clinically in Japan for over a decade to monitor short-term glycemic control. Evaluation of glucose control otherwise requires measuring plasma glucose or glycated proteins whose levels reflect average glucose concentration over the half-life of the protein analyzed. Hemoglobin A1c measurements reflect blood glucose levels over that past 2-3 months, while fructosamine can be used to evaluate glycemic control over 10-14 days. In contrast, 1,5-AG levels in blood respond within 24 h as a result of glucose's competitive inhibition of 1,5-AG reabsorption in the kidney tubule. When glucose levels rise, even transiently, urinary loss of 1,5-AG occurs, and circulating levels fall. Because of changes in renal hemodynamics in normal pregnancies, 1,5-AG appears of limited usefulness in evaluation of gestational diabetes. However, the characteristics of 1,5-AG levels in patients with moderate to near-normal glycemic control suggest that it may be a valuable complement to frequent self-monitoring or continuous monitoring of plasma glucose to confirm stable glycemic control. Measurements performed daily or weekly in a given patient would suggest that overall glycemic control has been stable or improved if 1,5-AG levels are stable or increasing. If 1,5-AG levels fall, greater attention to glucose monitoring and both lifestyle and medical management could be prescribed to correct the glycemic excursions that would underlie such changes. The behavior of this analyte is different from all others used in the management of diabetes, creating potential opportunities for its use in clinical practice.

Overview

Integrity signals

Registry

Crossref · 10.1089/152091503765691839

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 39 · Cited by 187

Research works printed but not linked: 2

  1. Stickle D, 1997, Am J Physiol, 273, E821
  2. Yamanouchi T, 1990, Am J Physiol, 258, E423

Metadata

Authors
Buse, J. B., Freeman, J. L. R., Edelman, S. V., Jovanovic, L., & McGill, J. B.
Affiliations
  • University of North Carolina at Chapel Hill (US)
  • BioEmerge Partners, Inc., Winston-Salem, North Carolina
  • University of California San Diego (US)
  • Sansum Medical Research Institute, Santa Barbara, California
  • Washington University in St. Louis (US)
Venue
Diabetes Technology & Therapeutics
Published
2003-06
Volume
5
Issue
3
Pages
355-363
ISSN
  • 1520-9156 (ISSN-L)
  • 1557-8593
OpenAlex
W1965776430
Cited by
187
References
39
Citations by year
2026: 3 · 2025: 6 · 2024: 16 · 2023: 7 · 2022: 14 · 2021: 8 · 2020: 9 · 2019: 11 · 2018: 13 · 2017: 10 · 2016: 9 · 2015: 15 · 2014: 12 · 2013: 10 · 2012: 8
FWCI
1.42
Type
journal article
Language
en
Open access
closed
Licence
www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)
Locations
  • Diabetes Technology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • McGill University
  • U.S. Food and Drug Administration
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
1,5-anhydroglucitol, glycemic control monitoring, diabetes management, tubular reabsorption, urinary excretion, gestational diabetes mellitus, self-monitoring of blood glucose, glycated proteins
MeSH terms
Blood Glucose, Deoxyglucose, Environmental Monitoring, Humans, Hyperglycemia, Isomerism, Japan, Gas Chromatography-Mass Spectrometry, Biomarkers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum 1,5-Anhydroglucitol (GlycoMark™): A Short-Term Glycemic Marker. https://app.cochat.ai/papers/10.1089/152091503765691839
The paper
Buse, J. B., Freeman, J. L. R., Edelman, S. V., Jovanovic, L., & McGill, J. B. (2003). Serum 1,5-Anhydroglucitol (GlycoMark™): A Short-Term Glycemic Marker. Diabetes Technology & Therapeutics. https://doi.org/10.1089/152091503765691839

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.